When pharmaceutical and biotech companies are working on their brand strategy and conducting brand planning it is vital that they understand what makes their healthcare customers tick.
A new report from Kantar Health sets out how brand leaders can identify key levers for driving growth within each pillar, from launch through to managing decline, and elevate the opportunities
Anyone who has taken a psychiatric medication knows that the status quo in prescribing is a trial and error approach, with patients often cycling through an array of drugs to find the one t
It’s 2024, and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another.